Clinical Trials Browser

Unknown × sintilimab × Breast × Clear all

NCT05386524 2023-02-16

Sintilimab and Bevacizumab Biosimilar Combined With PLD in mTNBC

Phase 2 Unknown

Breast Neoplasms

NCT05429684 2022-06-23

Precise Therapy for Refractory HER2 Positive Advanced Breast Cancer

Phase 3 Unknown

HER2+ Breast Cancer

NCT04809779 2021-03-22

NeoPD1TNBC

Phase 2 Unknown

Triple Negative Breast Neoplasms